Oncology News | pharmaphorum

News

BMS wins another lung cancer approval for its Opdivo+Yervoy ...

Bristol-Myers Squibb has won another first-line lung cancer approval from the FDA for its Opdivo and Yervoy immunotherapy combination.

News

NICE recommends Roche's Tecentriq in ES-SCLC following price...

NICE has said that Roche’s Tecentriq (atezolizumab) plus chemotherapy should be funded by the NHS as an option for untreated extensive-stage small-cell lung cancer (ES-SCLC) in second draft

News

NICE and Roche reach funding deal for Tecentriq in triple ne...

NICE has recommended regular NHS funding for Roche’s immunotherapy Tecentriq (atezolizumab) in tough-to-treat advanced triple negative breast cancer in final draft guidance, after a previou

News

There are three types of white blood cells. T lymphocytes, B lymphocytes and natural killer cells.

Kadmon preps filing for GVHD drug belumosudil after phase 3 ...

New York biotech Kadmon is on course to file for FDA approval of belumosudil for chronic graft versus host disease (GVHD) after it hit the mark in a pivotal trial.

News

AZ/Merck & Co take on Clovis as FDA approves prostate cancer...

The FDA has approved AstraZeneca and Merck & Co’s Lynparza (olaparib) in metastatic castration-resistant prostate cancer, just days after the regulator gave the nod for Clovis’ PARP-cla

News